Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr-Jun;2(2):82-7.
doi: 10.4161/oxim.2.2.8355.

Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation

Thissiane L Gonçalves  1 , Dalila M Benvegnú, Gabriela Bonfanti
Affiliations
Free PMC article

Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation

Thissiane L Gonçalves et al. Oxid Med Cell Longev. 2009 Apr-Jun.
Free PMC article

Abstract

Successful hematopoietic stem cell transplantation (HSCT), both autologous and allogeneic, requires a rapid and durable engraftment, with neutrophil (>500/microL) and platelet (>20,000/microL) reconstitution. Factors influencing engraftment after autologous or allogeneic HSCT were investigated in 65 patients: 25 autologous peripheral stem cell transplantation (PBSCT) and 40 allogeneic bone marrow transplantation (BMT) patients. The major factor affecting engraftment was the graft source for HSCT. Neutrophil and platelet recovery were more rapid in autologous PBSCT than in allogeneic BMT [neutrophil occurring in median on day 10.00 (09.00/11.00) and 19.00 (16.00/23.00) and platelet on day 11.00 (10.00/13.00) and 21.00 (18.00/25.00), respectively; p < 0.0001]. The type of disease also affected engraftment, where multiple myeloma (MM) and lymphoma showed faster engraftment when compared with leukemia, syndrome myelodysplastic (SMD) and aplastic anemia (AA) and MM presented the best overall survival (OS) in a period of 12 months. Other factors included the drug used in the conditioning regimen (CR), where CBV, melphalan (M-200) and FluCy showed faster engraftment and M-200 presented the best OS, in a period of 12 months and age, where 50-59 years demonstrated faster engraftment. Sex did not influence neutrophil and platelet recovery.

Keywords: bone marrow transplantation; conditioning regimen; engraftment; hematopoietic stem cell transplantation; peripheral blood stem cell transplantation.

PubMed Disclaimer

References

    1. Milla C, Yang S, Cornfiel DN, Brennan ML, Hazen SL, Mortari AP, et al. Myeloperoxidase deficiency enhances inflammation after allogenic marrow transplantation. Am J Physiol Lung Cell Mol Physiol. 2004;287:706–714. - PubMed
    1. Armitage JO. Medical progress: Bone marrow transplantation. N Engl J Med. 1994;330:827–838. - PubMed
    1. Horning SJ, Nademanee AP. Autologous hematopoietic cell transplantation for non-Hodgking lymphoma. Blackwell Science. 1999:939–951.
    1. Oyan B, Koc Y, Ozdemir E. Ifosfamide, idarubicin and etoposide in relapsed/refractory Hodgkin disease or non-Hodgking lymphoma: A savage regimen with high response rates before autologous stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:688–697. - PubMed
    1. Clift RA, Anasetti C. Allografting for chronic myeloid leukaemia. Baillieres Clin Haematol. 1997;10:319–336. - PubMed

Publication types

MeSH terms

LinkOut - more resources